Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2007
11/15/2007WO2005046572A3 Targeted delivery of controlled release polymer systems
11/15/2007WO2005040351A3 Compositions for inducing cell growth and differentiation and methods of using same
11/15/2007WO2002089857A3 Trans-viral vector mediated gene transfer to the retina
11/15/2007WO2001055313A3 Nucleic acids, proteins, and antibodies
11/15/2007US20070266450 Non-human animal alzheimer's disease model and uses thereof
11/15/2007US20070265220 Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
11/15/2007US20070265215 Antisense restenosis composition and method
11/15/2007US20070265197 Elastin-like polymer delivery vehicles
11/15/2007US20070265194 Agents for the treatment of viral infections
11/15/2007US20070265188 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions
11/15/2007US20070264339 Base-stabilized polyorthoester formulations
11/15/2007US20070264338 Base-stabilized polyorthoester formulations
11/15/2007US20070264321 Method of treating skin wounds with vectors encoding hepatocyte growth factor
11/15/2007US20070264282 Herpes virus strains for gene therapy
11/15/2007US20070264280 Compositions and Methods for Treating Neurological Diseases
11/15/2007US20070264275 Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy
11/15/2007US20070264273 Sphingoid polyalklamine conjugates, isomers and uses thereof
11/15/2007US20070264261 Methods of Therapy and Diagnosis Using Targeting of Cells that Express Killer Cell Immunoglobulin like Receptor like Proteins
11/15/2007US20070264256 polynucleotide sequence of a NTHi, polypeptides encoded by it and antibodies that bind to the polypeptide; detecting NTHi bacteria in a biological sample by contacting a polynucleotide to detect hybridization of the polynucleotide
11/15/2007US20070264254 Cardiac muscle function and manipulation
11/15/2007US20070264252 Modulators of Ms4a Gene Products
11/15/2007US20070264249 Gene-based lipid hydrolysis therapy for atherosclerosis and related diseases
11/15/2007US20070264244 Pigment epithelial cell of the eye, its production and use in therapy of an eye or CNS disease
11/15/2007US20070264243 Reversibly immortalized hepatocytes and methods of use
11/15/2007US20070264241 Compounds for Enhanced Cancer Therapy
11/15/2007US20070264236 Novel Therapeutic Fusion Proteins
11/15/2007US20070264235 Polypeptide Having an Improved Cytosine Deaminase Activity
11/15/2007US20070264234 Cytokine Variant Polypeptides
11/15/2007US20070264197 Method for detecting a progressive, chronic dementia disease, and corresponding peptides and detection reagents
11/15/2007US20070264191 Materials and Methods Relating to the Treatment of Glioblastomas
11/15/2007CA2651389A1 Novel reagents for transfection of eukaryotic cells
11/15/2007CA2651216A1 Aptamers directed to muc1
11/15/2007CA2648165A1 Biomarkers for endometrial proliferation
11/14/2007EP1854892A1 Modified viral surface proteins wich bind to cells of tumor vasculature
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854809A1 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
11/14/2007EP1854488A1 Methods for treatment of hyperproliferative diseases using human MDA-7
11/14/2007EP1854485A1 Preventives/remedies for cancer
11/14/2007EP1854473A1 Preventive/therapeutic agent for cancer
11/14/2007EP1853323A2 Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by insulin-like growth factor binding protein-3 (igfbp-3)
11/14/2007EP1853244A2 Method for the treatment of retinopathy of prematurity and related retinopathic diseases
11/14/2007EP1700120A4 Marker for neuromyelitis optica
11/14/2007EP1565212B1 Gastrin compositions and formulations, and methods of use and preparation
11/14/2007EP1373503B1 Neurotrophic factors
11/14/2007EP1339433B1 Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1117435B1 Mutant cholera holotoxin as an adjuvant
11/14/2007EP1114156B1 Mammalian transforming growth factor beta - 9 (ztgfss9)
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007CN101072879A Improved adenoviral vectors and uses thereof
11/14/2007CN101072878A Recombinant vector containing MJ1 gene and method of recombinant method using the same
11/14/2007CN101072876A Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells
11/14/2007CN101072875A Novel cancer antigen peptide and the use thereof
11/14/2007CN101072866A Method of altering cell properties by administering RNA
11/14/2007CN101072792A Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
11/14/2007CN101070547A Recombined protein carrier PEA II-HphA of actively carrying exogenic gene, its preparing method and use
11/14/2007CN101070544A HCV composite multi-epitope transgene plant oral vaccine
11/14/2007CN101070349A Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN100348725C Plasmid containing recombinant immunological toxin MIP-1ª‡-DT390 aiming at activated Th1 cell, its preparation method and uses
11/13/2007US7294755 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/13/2007US7294710 High-affinity choline transporter
11/13/2007US7294700 Anti-PRO846 antibodies
11/13/2007US7294504 For suppressing the expression of a gene targets and for degrading a target RNA using DNA as a vehicle
11/13/2007US7294496 Cloned human lysophospholipase
11/13/2007US7294477 Allergen and treatment
11/13/2007US7294333 Modifying the electrophysiological function of the heart and treating atrial fibrillation or ventricular tachycardia by implanting allogeneic or autogeneic fibroblasts expressing an exogenous voltage-gated or inward-rectifier potassium ion channel polypeptide into the heart
11/13/2007US7294331 Methods of using flt3-ligand in hematopoietic cell transplantation
11/13/2007CA2283637C Upar mimicking peptide
11/08/2007WO2007127981A2 Analyte-releasing beads and use thereof in quantitative elispot or fluorispot assay
11/08/2007WO2007127965A1 Treating glaucoma, cardiovascular diseases, and renal diseases
11/08/2007WO2007127882A2 An isolated dna fragment of the human a33 promoter and its use to control the expression of a heterologous gene in tumor cells
11/08/2007WO2007127393A2 Treatment and screening methods for promoting neurogenesis
11/08/2007WO2007127290A2 Method for producing viral vaccine and therapeutic peptide antigens
11/08/2007WO2007127163A2 Cns-tumor treatment method and composition
11/08/2007WO2007127020A2 Nucleic acid nanotube liquid crystals and use for nmr structure determination of membrane proteins
11/08/2007WO2007126887A2 Immunogenic compositions comprising polynucleotides encoding matrix protein 2 and methods of use
11/08/2007WO2007126813A2 Cross-reactive monoclonal antibodies recognizing als family proteins
11/08/2007WO2007126457A2 Method and composition for treating and preventing tumor metastasis in vivo
11/08/2007WO2007126386A1 Exosome transfer of nucleic acids to cells
11/08/2007WO2007126150A1 Novel composition for treating cancer
11/08/2007WO2007125723A1 Glomerular slit protein inducer
11/08/2007WO2007125621A1 Novel use of gene whose expression is increased in hyperplastic pancreatic islet
11/08/2007WO2007124573A1 High-titer retroviral packaging cells
11/08/2007WO2007072221A3 Surface marker-directed cancer therapeutics
11/08/2007WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007WO2007011601A3 Cancer treatment using viruses, fluoropyrimidines and camptothecins
11/08/2007WO2006137836A3 Bacterial vector systems
11/08/2007WO2006088849A8 Metabolic-based methods for modulating gene expression
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007WO2002046220A9 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/08/2007US20070261126 Methods and sequences to suppress primate huntington gene expression in vivo
11/08/2007US20070259831 Treatment and screening methods for promoting neurogenesis
11/08/2007US20070259830 compounds having a chelating moiety and an oligonucleotide sequence which includes one or more modified nucleobases such as hydroxynucleobases; inhibiting translation of a nucleic acid in an organism
11/08/2007US20070259813 Anti-Bacterial Composition Especially for Controlling Gram-Negative Bacteria, Comprising a Peptide and an Advantageously Hydrophobic Anti-Bacterial Agent
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 870